LG Chem: Hepatitis B trials

The registry lists 13 Hepatitis B studies with LG Chem as lead sponsor. 2 are open to participants now and 0 have results posted.

Phase 1 4Phase 2 7Phase 3 3Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of AgeNot yet recruitingNCT06618196Phase 2
• A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy AdultsNot yet recruitingNCT05952596Phase 1
• A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary SeriesActive, not recruitingNCT06947499Phase 2/3
• Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary SeriesCompletedNCT05457946Phase 2/3
• Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy InfantsStatus unknownNCT04073459Phase 2
• A Phase IV Study to Assess the Safety of EupentaTM InjStatus unknownNCT04056728Phase 4
• A Study to Compare LBVD to Eupenta and Imovax Polio in Healthy AdultsCompletedNCT03208101Phase 1
• Post-authorization Safety Study of Euforvac-Hib Vaccine for Active Primary Immunization in Infants From 6 WeeksStatus unknownNCT02257645
• A Phase III Study to Assess the Immunogenicity and Safety of Eutravac (DTap-HB Combined Vaccine) With DTaP and Hepatitis B Vaccines in Healthy InfantsCompletedNCT01896739Phase 3
• Bioequivalence of LB80380 Free Base and Maleate Salt TabletsCompletedNCT01427868Phase 1
• Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BStatus unknownNCT01242787Phase 2
• Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BCompletedNCT01026610Phase 2
• Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis BCompletedNCT00895596Phase 1/2